Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3024% below fair value
$17.06−1.42 (-7.68%)
Close on Nov 17, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Tandem Diabetes Care's enterprise value was $1.45B on Nov 11, 2026, against $1.41B a year earlier. Over the last 5 years it ranged from $618.33M to $8.96B, with a median of $1.70B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.45B | -1.9% |
| 2025 | Dec 31, 2025 | $1.48B | -33.9% |
| 2024 | Dec 31, 2024 | $2.24B | +56.6% |
| 2023 | Dec 29, 2023 | $1.43B | -37.3% |
| 2022 | Dec 30, 2022 | $2.28B | -74.5% |
| 2021 | Dec 31, 2021 | $8.96B | +63.5% |
| 2020 | Dec 31, 2020 | $5.48B | +63.0% |
| 2019 | Dec 31, 2019 | $3.36B | +62.8% |
| 2018 | Dec 31, 2018 | $2.06B | +2616.2% |
| 2017 | Dec 29, 2017 | $76.01M | -0.6% |
| 2016 | Dec 30, 2016 | $76.48M | -74.7% |
| 2015 | Dec 31, 2015 | $302.89M | +38.6% |
| 2014 | Dec 31, 2014 | $218.47M | – |
| 2013 | Dec 31, 2013 | -$12.32M | – |
See a number that looks wrong?